A. Sáez

发表

Anomalous high p27/KIP1 expression in a subset of aggressive B-cell lymphomas is associated with cyclin D3 overexpression. p27/KIP1-cyclin D3 colocalization in tumor cells.

M. Piris, M. Sánchez-Beato, L. Sánchez-Verde, 1999, Blood.

Anomalous high p27/KIP1 expression in a subset of aggressive B-cell lymphomas is associated with cyclin D3 overexpression. p27/KIP1-cyclin D3 colocalization in tumor cells.

Juan F. García, M. Piris, M. Sánchez-Beato, 1999 .

Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays.

Lydia Sánchez, Manuel Morente, Máximo Fraga, 2003, Blood.

Cyclin-dependent kinase inhibitor p27KIP1 in lymphoid tissue: p27KIP1 expression is inversely proportional to the proliferative index.

M. Piris, M. Sánchez-Beato, G. Troncone, 1997, The American journal of pathology.

Analysis of Octamer-Binding Transcription Factors Oct2 and Oct1 and their coactivator BOB.1/OBF.1 in Lymphomas

Juan F. García, M. Piris, R. Franco, 2002, Modern Pathology.

chemoimmunotherapy miRNA expression in diffuse large B-cell lymphoma treated with

E. González-Barca, D. Pisano, M. Piris, 2013 .

Array comparative genomic hybridization identifies genetic regions associated with outcome in aggressive diffuse large B‐cell lymphomas

Marcos González, J. Hernández, M. Piris, 2009, Cancer.

Overall survival in aggressive B-cell lymphomas is dependent on the accumulation of alterations in p53, p16, and p27.

A. Sánchez-Aguilera, M. Piris, M. Sánchez-Beato, 2001, The American journal of pathology.

Expression of p21WAF1/CIP1 in fetal and adult tissues: simultaneous analysis with Ki67 and p53.

M. Piris, M. Sánchez-Beato, J. L. Orradre, 1997, Journal of clinical pathology.

p27K'Pl Expression IsInversely Proportional tothe Proliferative Index

M. Sánchez-Beato, G. Troncone, L. Sánchez-Verde, 1997 .

Identification of biological markers of sensitivity to high-clinical-risk-adapted therapy for patients with diffuse large B-cell lymphoma

J. Hernández, M. Piris, J. Rodríguez, 2009, Leukemia & lymphoma.

Expression of p2 1 in fetal and adult tissues: simultaneous analysis with Ki67 and p53

M. Piris, M. Mateo, J. Martínez, 2022 .

Lymphoepithelioma-like carcinoma of the bladder: three cases with clinicopathological and p53 protein expression study

A. Sáez, A. Pérez‐Rosado, F. Izquierdo-García, 2004, Virchows Archiv.

Cutaneous Follicular B-Cell Lymphoma: Description of a Series of 18 Cases

M. Piris, F. López-Ríos, J. Rodríguez-Peralto, 2001, The American journal of surgical pathology.

Unique phenotypic profile of monocytoid B cells: differences in comparison with the phenotypic profile observed in marginal zone B cells and so-called monocytoid B cell lymphoma.

M. Piris, M. Sánchez-Beato, L. Sánchez-Verde, 2001, The American journal of pathology.

Multifocal intrafollicular granulosa cell tumor of the ovary associated with an unusual germline p53 mutation

A. Sáez, M. Robledo, F. Nogales, 2004, Modern Pathology.

Widespread cutaneous necrosis and antiphospholipid antibodies: two episodes related to surgical manipulation and urinary tract infection.

A. Sáez, C. Soria, C. Schoendorff, 1997, Journal of the American Academy of Dermatology.

Loss of p16 protein expression associated with methylation of the p16INK4A gene is a frequent finding in Hodgkin's disease.

M. Piris, L. Sánchez-Verde, J. Martínez-Montero, 1999, Laboratory investigation; a journal of technical methods and pathology.

Loss of p16/INK4A protein expression in non-Hodgkin's lymphomas is a frequent finding associated with tumor progression.

J. Benítez, M. Piris, M. Sánchez-Beato, 1998, The American journal of pathology.

A short mutational hot spot in the first intron of BCL-6 is associated with increased BCL-6 expression and with longer overall survival in large B-cell lymphomas.

M. Piris, M. Sánchez-Beato, A. Sáez, 2002, The American journal of pathology.

Overexpression of human DNA polymerase mu (Pol mu) in a Burkitt's lymphoma cell line affects the somatic hypermutation rate.

M. Piris, L. Blanco, Manuel A. González, 2004, Nucleic acids research.

Development of a Real-Time Reverse Transcription Polymerase Chain Reaction Assay for c-myc Expression That Allows the Identification of a Subset of c-myc+ Diffuse Large B-Cell Lymphoma

J. Cigudosa, M. Piris, M. Sánchez-Beato, 2003, Laboratory Investigation.

Building an outcome predictor model for diffuse large B-cell lymphoma.

Ramón Bosch, Marina Pollán, Máximo Fraga, 2004, The American journal of pathology.

miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy.

Ronald S Go, David G Pisano, Juan F. García, 2011, Blood.

Fulminant hemophagocytic syndrome as presenting feature of T-cell lymphoma and Epstein-Barr virus infection.

A. Sáez, E. Grau, E. Real, 2000, Haematologica.

Stratifying diffuse large B-cell lymphoma patients treated with chemoimmunotherapy: GCB/non-GCB by immunohistochemistry is still a robust and feasible marker

Ken H. Young, Lydia Sánchez, Alexandar Tzankov, 2016, Oncotarget.

Prognostic Value of cMYC Gene Abnormalities in Diffuse Large B Cell Lymphoma Treated with Chemo-Immunotherapy

Juan F. García, E. González-Barca, M. Piris, 2011 .

Piris PRDM 1 / BLIMP-1 expression in multiple B and T-cell lymphoma

Juan F. García, T. Marafioti, L. Maestre, 2006 .

Clinical outcome in diffuse large B-cell lymphoma is dependent on the relationship between different cell-cycle regulator proteins.

M. Piris, E. Sánchez, J. L. Orradre, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy.

Juan F. García, E. González-Barca, D. Pisano, 2011, Blood.